Performance driven by core drug discovery, continued adoption in environmental toxicology, and launch of new assays and ...

Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...

Symeres, Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer: Nijmegen, Netherlands Thursday, April 2, 2026, 12:00 Hrs [IST] Symeres, a leading CRDMO ...

UK biotech Semarion has secured $3.8 million (£2.9 million) to expand manufacturing and commercial reach of its cell-based ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...

Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the ...

KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...

Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are characterized by the abnormal aggregation of pathological proteins ...

As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision ...

The findings are notable because thrombotic complications are often emphasized in cancer care, yet this analysis found that ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...